8 July 2004 DIRECTOR’S SERVICE AGREEMENT between ACAMBIS plc - and - DAVID MUIR LAWRENCE Weil, Gotshal & Manges One South Place London EC2M 2WG Tel: +44 (0) 20 7903 1000 Fax: +44 (0) 20 7903 0990 www.weil.comAcambis PLC • June 30th, 2005 • Pharmaceutical preparations • England
1. THIS CONTRACT IS A RATED ORDER RATING PAGE OF PAGES AWARD/CONTRACT UNDER DPAS (15 CFR 350) 4 N/A 1 27 2. CONTRACT (Proc. Inst. Ident.) NO. 3. EFFECTIVE DATE 4. REQUISITION/PURCHASE REQUEST/PROJECT NO. HHSN266200400071C September 30, 2004 VRCB148 5....Acambis PLC • June 30th, 2005 • Pharmaceutical preparations
Unique research resources arising from NTH-funded research are to be shared with the scientific research community. NTH provides guidance, entitled, “Sharing Biomedical Research Resources: Principles and Guidelines for Recipients of NIH Research Grants and Contracts,” (Federal Register Notice, December 23, 1999 [64 FR 72090]), concerning the appropriate terms for disseminating and acquiring these research resources. This guidance, found at: http://ott.od.nih.gov/NewPages/64FR72090.pdf. is intended to help contractors ensure that the conditions they impose and accept on the transfer of research tools will facilitate further biomedical research, consistent with the requirements of the Bayh-Dole Act and NIH funding policy.
ASSET PURCHASE AGREEMENT by and between BioReliance Corporation and Acambis Inc. Dated May 6, 2005Asset Purchase Agreement • June 30th, 2005 • Acambis PLC • Pharmaceutical preparations • Maryland
This Asset Purchase Agreement (“Agreement”) is dated May 6, 2005 (“Effective Date”), by and between Acambis Inc., a Delaware corporation with offices at 38 Sidney Street, Cambridge, MA 02139 (“Buyer”) and BioReliance Corporation, a wholly owned subsidiary of Invitrogen Corporation, a Delaware corporation, with offices at 14920 Broschart Road, Rockville, MD 20850 (“Seller”).
